SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.
more
Refresh
No publications yet
Add SillaJen Inc to your Watchlist to get alerts on new publications